======= PHYKPL =======
== Gene Information ==
* **Official Symbol**: PHYKPL
* **Official Name**: 5-phosphohydroxy-L-lysine phospho-lyase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=85007|85007]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUZ5|Q8IUZ5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PHYKPL&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHYKPL|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614683|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This is a nuclear gene encoding a mitochondrial enzyme that catalyzes the conversion of 5-phosphonooxy-L-lysine to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. Mutations in this gene may cause phosphohydroxylysinuria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013].
* **UniProt Summary**: Catalyzes the pyridoxal-phosphate-dependent breakdown of 5-phosphohydroxy-L-lysine, converting it to ammonia, inorganic phosphate and 2-aminoadipate semialdehyde. {ECO:0000269|PubMed:22241472}.
|Aminotran 3|
|transaminase activity|
|lysine catabolic process|
|lysine metabolic process|
|lyase activity|
|aspartate family amino acid catabolic process|
|collagen catabolic process|
|aspartate family amino acid metabolic process|
|pyridoxal phosphate binding|
|collagen metabolic process|
|alpha-amino acid catabolic process|
|cellular amino acid catabolic process|
|alpha-amino acid metabolic process|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|cellular amino acid metabolic process|
|mitochondrial matrix|
|small molecule catabolic process|
|carboxylic acid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|identical protein binding|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.96|
|[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.85|
|[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-1.71|
|[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.88|
|[[:results:exp291|LLY-284 2.6μM R06 exp291]]|2.12|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9241
* **Expression level (log2 read counts)**: 5.55
{{:chemogenomics:nalm6 dist.png?nolink |}}